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A unique heterozygous 3-kb microdeletion within STX16, a closely linked gene centromeric of GNAS, was previously
identified in multiple unrelated kindreds as a cause of autosomal dominant pseudohypoparathyroidism type Ib (AD-
PHP-Ib). We now report a novel heterozygous 4.4-kb microdeletion in a large kindred with AD-PHP-Ib. Affected
individuals from this kindred share an epigenetic defect that is indistinguishable from that observed in patients
with AD-PHP-Ib who carry the 3-kb microdeletion in the STX16 region (i.e., an isolated loss of methylation at
GNAS exon A/B). The novel 4.4-kb microdeletion overlaps with the previously identified deletion by 1,286 bp
and, similar to the latter deletion, removes several exons of STX16 (encoding syntaxin-16). Because these micro-
deletions lead to AD-PHP-Ib only after maternal transmission, we analyzed expression of this gene in lymphoblastoid
cells of affected individuals with the 3-kb or the 4.4-kb microdeletion, an individual with a NESP55 deletion, and
a healthy control. We found that STX16 mRNA was expressed in all cases from both parental alleles. Thus, STX16
is apparently not imprinted, and a loss-of-function mutation in one allele is therefore unlikely to be responsible
for this disorder. Instead, the region of overlap between the two microdeletions likely harbors a cis-acting imprinting
control element that is necessary for establishing and/or maintaining methylation at GNAS exon A/B, thus allowing
normal Gas expression in the proximal renal tubules. In the presence of either of the two microdeletions, parathyroid
hormone resistance appears to develop over time, as documented in an affected individual who was diagnosed at
birth with the 4.4-kb deletion of STX16 and who had normal serum parathyroid hormone levels until the age of
21 mo.
Introduction
GNAS is a complex imprinted locus that yields—in ad-
dition to the a-subunit of the stimulatory G protein
(Gas)—multiple alternative transcripts (fig. 1). These tran-
scripts encode extra-large Gas (XLas) (Kehlenbach et al.
1994; Hayward et al. 1998a; Peters et al. 1999) or neu-
rosecretory protein 55 (NESP55) (Ischia et al. 1997; Hay-
ward et al. 1998b; Peters et al. 1999), or they lead to
presumably nontranslated RNAs, such as the A/B tran-
script (also referred to as “1A” or “1′”) (Ishikawa et al.
1990; Swaroop et al. 1991; Liu et al. 2000b) and the
antisense (AS) transcript (referred to as “Nespas” in
mouse) (Hayward and Bonthron 2000; Liu et al. 2000b;
Wroe et al. 2000). NESP55, XLas, and A/B differ from
Gas only by their first exons, whereas AS transcripts con-
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sist of entirely distinct exons. AS, XLas, and A/B are pa-
ternally derived transcripts, whereas NESP55 is a mater-
nally derived transcript. Consistent with their monoallelic
expression, the promoters of these imprinted transcripts
are located within differentially methylated regions
(DMRs) (fig. 1). In contrast, the promoter that gives rise
to Gas is not methylated, and, accordingly, expression of
Gas occurs in most tissues from both parental GNAS
alleles (Campbell et al. 1994; Hayward et al. 1998a,
1998b; Zheng et al. 2001). In some tissues (including
proximal renal tubules, pituitary, gonads, and thyroid),
however, Gas transcripts are predominantly derived from
the maternal allele (Hayward et al. 1998a, 2001; Yu et
al. 1998; Li et al. 2000; Mantovani et al. 2002).
Pseudohypoparathyroidism (PHP) is a disorder char-
acterized by hypocalcemia, hyperphosphatemia, and
parathyroid hormone (PTH) levels that are elevated as
a result of end-organ resistance to this hormone. One of
the two main subtypes of PHP, PHP type Ia (PHP-Ia
[MIM 103580]), is caused by heterozygous maternally
inherited loss-of-function mutations in GNAS exons
1–13, which encode Gas. In addition to PTH resistance,
affected individuals typically show clinical abnormali-
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Figure 1 Schematic representation of the human STX16 and GNAS loci (not to scale). Exons are depicted as blackened boxes; arrows
indicate direction (sense, antisense) and allelic origin (Mat p maternal [above the line]; Patp paternal [below the line]) of transcription. Note
that Gas is transcribed from both alleles in most tissues (Campbell et al. 1994; Hayward et al. 1998a, 1998b; Zheng et al. 2001) and that the
paternal allele is silenced (dotted arrow) in some tissues, including kidney, adipose tissue, and pituitary (Hayward et al. 1998a, 2001; Yu et al.
1998; Li et al. 2000; Mantovani et al. 2002). Paternal and maternal DMRs are indicated by blackened and unblackened rectangles, respectively.
ties referred to as “Albright hereditary osteodystrophy”
(AHO) and resistance toward several additional hor-
mones, including thyroid-stimulating hormone (TSH)
and gonadotropins. When inherited paternally, Gas loss-
of-function mutations are associated with AHO alone,
in the absence of hormonal resistance—a variant termed
“pseudopseudohypoparathyroidism” (PPHP) (Weinstein
et al. 2001; Levine 2002). The other main form of PHP,
PHP type Ib (PHP-Ib [MIM 603233]), differs from PHP-
Ia and PPHP, in that PHP-Ib patients do not have the
AHO phenotype (Weinstein et al. 2001). Furthermore,
hormone resistance in PHP-Ib appears to be limited to
the renal actions of PTH, although resistance to TSH is
also seen occasionally (Bastepe et al. 2001a, 2001b; Liu
et al. 2003).
The autosomal dominant variant of PHP-Ib (AD-
PHP-Ib) has been linked to a region of chromosome
20q13.3 that comprises the GNAS locus, and, similar
to PHP-Ia, this disorder is maternally transmitted (Ju¨p-
pner et al. 1998). Most individuals affected by AD-PHP-
Ib show a methylation defect that is limited to GNAS
exon A/B, whereas most apparently sporadic cases of
the disease display abnormal methylation at other
GNAS DMRs as well (Liu et al. 2000a, 2005; Bastepe
et al. 2001b, 2003). An identical 3-kb microdeletion
located ∼220 kb upstream of GNAS has been identified
in all affected members and obligate carriers of 14 un-
related families with AD-PHP-Ib and in two apparently
sporadic cases (Bastepe et al. 2003). All affected indi-
viduals share the same epigenetic defect at exon A/B
and lack methylation abnormalities at the other DMRs
of GNAS. The 3-kb microdeletion lies between two
direct repeats and removes intronic as well as exonic
sequences of the gene encoding syntaxin-16 (STX16).
Consistent with the imprinted inheritance pattern of the
disease, transmission of the microdeletion from a female
obligate carrier causes PTH resistance, whereas trans-
mission of the same mutation from a male obligate car-
rier results in normal PTH responsiveness (Bastepe et
al. 2003). Recently, additional patients with PHP-Ib and
with the isolated GNAS exon A/B methylation defect
have been reported to carry the same 3-kb microdeletion
(Liu et al. 2005; Mahmud et al. 2005), thereby strength-
ening the likely causative association between the exon
A/B methylation defect and this deletion.
In one family with AD-PHP-Ib (kindred W), the 3-
kb microdeletion was not found, despite a loss of meth-
ylation at GNAS exon A/B alone in the affected in-
dividuals (Bastepe et al. 2001b, 2003), suggesting the
presence of another mutation in the STX16 region. We
thus searched, in this family, for mutations within
STX16 and identified a novel microdeletion in all af-
fected members and unaffected carriers.
Subjects and Methods
Kindred W and Methylation Analysis of GNAS Exon
A/B
The pedigree (kindred W) and the clinical and labo-
ratory data of most members of this family have been
described elsewhere (Bastepe et al. 2001b) (see also fig.
2A). Genomic DNA was isolated from blood leukocytes
of all family members, and a lymphoblastoid cell line
was established for patient W-III/3 (Harvard-Partners
Center for Genetics and Genomics Biosample Services
Facility). Written informed consent was obtained from
all investigated individuals (Massachusetts General Hos-
pital institutional review board [#2001p-000648]).
Since 2001, when this family was first reported (Bas-
tepe et al. 2001b), two children have been born: W-III/
12 (born to W-II/9) and W-III/13 (born to W-II/10). Ge-
nomic DNA was extracted from cord blood of both
children. Methylation of GNAS exon A/B was assessed
by nucleotide sequence analysis of PCR-amplified bi-
sulfite-treated genomic DNA and by Southern blot an-
alysis with the use of EagI (methylation sensitive) and
EcoRV (methylation insensitive) (New England Biolabs),
as described elsewhere (Ju¨ppner et al. 1998; Bastepe et
al. 2001b, 2003). Total serum calcium, phosphorus, in-
tact PTH (Nichols Institute), and TSH were measured
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Figure 2 A, Evidence of allelic loss within the STX16 locus in the obligate carriers W-II/5 and W-II/6. All the affected individuals (blackened
symbols) as well as the obligate carriers (striped symbols) share the same disease-associated haplotype (gray columns) at 20q13.3; note that
not all investigated markers are shown. A recombination event occurred in individual W-II/9 between markers 907-rep2 and 261P9-CA1 and
was transmitted to her affected daughter, W-III/12, thus reducing the critical interval likely containing the genetic lesion that causes AD-PHP-
Ib. Evidence of allelic loss was found at SNP rs6100157 (bold typeface) in obligate carriers W-II/5 and W-II/6. B, Loss of methylation at GNAS
exon A/B in the newborn W-III/12. The methylation status of GNAS exon A/B was assessed by Southern blot analysis of cord blood DNA
from patient W-III/12 and of genomic DNA from her unaffected mother (W-II/9), an individual with paternal uniparental isodisomy of chro-
mosome 20q (“UPD”) (Bastepe et al. 2001a), and a healthy control individual (“N”). These samples were digested with a methylation-sensitive
(EagI) and a methylation-insensitive (EcoRV) restriction endonuclease, as described elsewhere (Bastepe et al. 2001b). Locations of restriction
sites and their methylation status (“” p methylated; “” p nonmethylated), the predicted fragments, and the probe (gray bar) are shown
in the left panel. Affected individuals (UPD and W-III/12) show loss of methylation at exon A/B, whereas unaffected individuals (N and W-II/
9) have one methylated and one nonmethylated allele. Fragment sizes are indicated by arrowheads. Note that the faint hybridizing band below
the 6.2-kb band reflects partial methylation (“/”) and, hence, incomplete digestion at one of the EagI sites between exon A/B and Gas exon 1.
in patient W-III/12 shortly after birth and subsequently
at regular intervals.
Analysis of Microsatellite Markers and SNPs
Microsatellite markers D20S102, D20S25, D20S86,
D20S164, 907-Rep2, 907-Rep4, 261P9-CA1, 806M20-
CA, AFM248tf5, GNAS, 543J19-TTA, D20S171, st-
AFMa202yb9, and D20S93 were analyzed as described
elsewhere (Bastepe et al. 2003). SNPs rs6100157,
rs2296524, and rs6100158—which correspond to
nucleotides 3959, 4712, and 5326, respectively, of
AL139349—were analyzed by nucleotide sequence anal-
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Table 1
Sequences of the Primers Used in the Present Study
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
ysis after PCR amplification, which was performed using
conditions and primers reported elsewhere (table 1) (Ju¨p-
pner et al. 1998; Bastepe et al. 2001b, 2003).
Southern Blot and PCR Analysis for Detection
of the Deletion
For Southern blot analysis, genomic DNA (5 mg) was
digested with AflII, BclI, or BglII (New England Biolabs).
After separation on a 0.8% agarose gel, DNA fragments
were transferred onto a nitrocellulose filter and were
hybridized with a 32P-radiolabeled probe (nucleotides
8299–9921 of AL139349), which was generated by PCR;
primers are listed in table 1.
PCR amplification of genomic DNA across the pre-
dicted deletion was performed using primers 5.9 kb
apart from each other (primers A and B) (table 1) and
the Expand Long-Template PCR System with Buffer 3
(Roche Molecular Biochemicals). The cycling conditions
were an initial 94C for 3 min; 10 cycles of 94C for 10
s, 58C for 30 s, and 68C for 5 min; 25 cycles of 94C
for 10 s, 58C for 30 s, and 68C for 5 min, with an
additional 20 s at 68C after each cycle; and 1 final cycle
at 72C for 10 min. These conditions yielded a 5.9-kb
amplicon, which was not consistently amplified in all
samples. The same conditions also yielded an ∼1.5-kb
amplicon in affected individuals and obligate carriers,
which was gel purified and submitted for nucleotide se-
quence analysis (Massachusetts General Hospital DNA
Core Facility).
For multiplex PCR, two pairs of primers (C and D,
E and F) were designed, to amplify small fragments
across each boundary of the deletion (table 1). Both pairs
were used for simultaneous PCR amplification of three
different fragments: a 616-bp fragment (primers C and
D) and a 252-bp fragment (primers E and F), derived
from the centromeric and telomeric ends of the deleted
region, respectively, as well as a 4.8-kb fragment (prim-
ers C and F), derived from the wild-type allele. As a
result of its large size, however, the latter fragment could
not be effectively amplified each time.
Analyzing STX16 Transcripts
Total RNA was extracted from lymphoblastoid cells
derived from the affected individuals W-III/3, F-III/37,
C-II/1, as well as a healthy control individual (Harvard-
Partners Center for Genetics and Genomics Biosample
Services Facility). Subject F-III/37 carries the previously
described 3-kb deletion (Bastepe et al. 2003). Subject C-
II/1 has methylation abnormalities at all GNAS DMRs
and has been recently shown to carry a novel micro-
deletion involving exon NESP55 and antisense exons 3
and 4 (Bastepe et al. 2005). Consistent with the con-
clusion that the STX16 region is intact, subject C-II/1
was furthermore shown to be heterozygous at SNPs
rs6100157 and rs2296524, which are located within the
centromeric repeat and STX16 exon 4, respectively.
STX16 mRNAs were amplified by RT-PCR. One mi-
crogram of lymphoblast-derived total RNA was reverse
transcribed using Superscript II (Invitrogen) and oligo
(dT) primers, in accordance with manufacturer recom-
mendations; the same reactions, without reverse tran-
scriptase, served as negative controls. PCR was then
performed using 1 ml of 1:10 dilution of the reverse-
transcription mixture, a forward primer located in ex-
on 1 (primer G), and a reverse primer located in exon 8
(primer H) in a total reaction volume of 50 ml (table 1
and fig. 3). The amplification conditions were an initial
94C for 2 min; 31 cycles of denaturation at 95C for
30 s, annealing at 61C for 30 s, and extension at 72C
for 1 min; and 1 final cycle of extension at 72C for 10
min. Amplicons were separated on a 2% agarose gel,
were purified, and were submitted for nucleotide se-
quence analysis (Massachusetts General Hospital DNA
Core Facility), as described elsewhere (Bastepe et al.
2001b). To determine the allelic origin of the STX16
transcripts in the healthy control individual and in sub-
ject C-II/1, total RNA was amplified by RT-PCR as de-
scribed above, and the polymorphic nucleotide at po-
sition 527 of STX16 isoform B was analyzed by direct
sequence analysis of the amplicon; this corresponds to
SNP rs2296524 (table 1).
Results
Loss of Exon A/B Methylation and Development
of PTH Resistance
We have reported elsewhere that affected members of
kindred W show a loss of exon A/B methylation without
additional epigenetic defects of GNAS (Bastepe et al.
2003). Nucleotide sequence analysis of PCR-amplified
bisulfite-treated cord blood DNA from the newborn W-
III/13 showed a normal methylation pattern at GNAS
exon A/B (data not shown). Accordingly, haplotype an-
alysis across the GNAS region revealed that this in-
dividual had inherited the grandmaternal haplotype,
which is not associated with disease (fig. 2A) (Bastepe
et al. 2001b). Thus, two independent approaches indi-
cated that subject W-III/13 would not be affected with
AD-PHP-Ib. In contrast, Southern blot analysis of cord
blood DNA from his cousin, W-III/12, performed using
the restriction endonucleases EcoRV and EagI, showed
loss of methylation at GNAS exon A/B (fig. 2B), and
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Figure 3 Delayed onset of PTH resistance in patient W-III/12.
Serum calcium, phosphorus, and PTH levels were measured during
follow-up visits of the patient—in whom loss of methylation at GNAS
exon A/B was identified at birth—and the 4.4-kb deletion was dis-
covered subsequently. Normal ranges are indicated by gray shading.
Treatment with an active vitamin D analog (Rocaltrol) was first started
at age 21 mo (vertical arrow). However, the parents discontinued the
treatment shortly thereafter, and continuous treatment was not re-
sumed until the child was 30 mo old (horizontal arrow).
haplotype analysis revealed inheritance of the disease-
associated grandpaternal haplotype (fig. 2A). She was
therefore predicted to develop PTH resistance, which
was subsequently documented (see below). Because pa-
tient W-III/12 was found to be affected, the maximum
LOD score increased from 2.03 (Bastepe et al. 2001b)
to 2.43 for genetic linkage to 20q13.3 (D20S171 [vp0]),
increasing the likelihood that the defect leading to AD-
PHP-Ib in this family also resides close to the GNAS
locus.
Birth weight and height of patient W-III/12 were 4.2
kg (95th percentile [North American reference chart])
and 53 cm (95th percentile), respectively. Her weight,
height, and BMI remained above the 95th percentile dur-
ing infancy and early childhood. Except for being over-
weight, she had no features suggestive of AHO. PTH
resistance was absent at birth but developed by age 21
mo, when serum PTH levels were first noted to be above
the normal range (188 pg/ml; normal range 10–65 pg/
ml). Both total serum calcium and phosphorous con-
centrations remained within normal range during this
period, although serum phosphorus was close to the up-
per limit (fig. 3). Because of the genetic findings and the
elevation in PTH concentration, treatment with an active
vitamin D analog (Rocaltrol) and calcium supplements
was first initiated at age 21 mo. However, the parents
discontinued these medications shortly thereafter, and it
was not until the child was 30 mo old that uninterrupted
treatment was started. By that time, the PTH concen-
tration had increased to 386 pg/ml. In addition, mild
TSH resistance was suspected at age 30 mo because of
elevated TSH (14.5 mUI/l; normal range 0.5–5 mUI/l),
normal free T4 (0.9 ng/dl; normal range 0.7–1.7 ng/dl),
and undetectable serum anti-thyroglobulin and anti-
thioperoxidase antibodies. L-thyroxine treatment was
then started, and the TSH level dropped to the normal
range (2.89 mUI/l at 41 mo).
Identification of a Novel Deletion within the STX16
Region
All affected individuals of kindred W (W-III/3, W-III/
7, W-III/8, and W-III/12) showed a loss of methylation
at GNAS exon A/B, without methylation abnormalities
involving the NESP55, XL, or AS DMRs (fig. 2B and
Bastepe et al. [2001b]). Nevertheless, unlike many other
kindreds with AD-PHP-Ib with the same epigenetic de-
fect, the previously described 3-kb deletion (nucleotides
3786–6764 of AL139349) could not be found in this
kindred. In fact, all affected individuals and obligate car-
riers were heterozygous at microsatellite marker 261P9-
CA1, and some of them, furthermore, were heterozygous
at SNP rs6100158 (figs. 2A and 4A). In addition, PCR
analysis across the 3-kb deletion, performed using pre-
viously established primers and conditions (Bastepe et al.
2003), revealed no evidence of a smaller deletion within
this region.
Analysis of additional polymorphisms centromeric of
the heterozygous SNP rs6100158 revealed allelic loss at
SNP rs6100157 for the obligate carriers W-II/5 and W-
II/6, indicating the presence of a deletion comprising this
region (figs. 2A and 4A). This deletion was confirmed
by Southern blot analysis of genomic DNA from indi-
vidual W-II/5 and her unaffected child W-III/4, per-
formed using restriction enzymes AflII, BclI, or BglII (fig.
4B). The probe, located telomeric of SNP rs6100158,
detected wild-type hybridizing fragments of 7.9 kb, 9.8
kb, and 9.2 kb in both samples. In addition, however,
hybridizing AflII, BclI, and BglII fragments of ∼6.8 kb,
11.1 kb, and 7 kb were detected, respectively, in the
DNA sample from individual W-II/5 but not in the DNA
Figure 4 Identification of a novel 4.4-kb deletion in kindred W. A, Simplified map of the 20q13.3 region and the localization of the two
known microdeletions. Sequence of the depicted region is included in AL050327 (clone 907D15) and AL139349 (clone 261P9). Exons are
depicted as blackened rectangles, and direct repeats are shown as striped arrowheads. The 3-kb and 4.4-kb deleted regions lie between the thin
and thick brackets, respectively. The locations of recognition sites for the restriction endonucleases used in the Southern blot analysis are shown
under the gene map. The location of the 1.6-kb probe is marked by the gray bar, and primers A, B, C, D, E, and F, which were used for PCR
analyses, are indicated by arrowed lines; cen p centromeric; tel p telomeric; N p NESP55; AS p antisense; X p XLas; A/B p exon A/B.
B, Southern blot analysis of genomic DNA from an unaffected (“U”) subject, W-III/4, and an obligate carrier (“OC”), W-II/5, which was
digested with three different restriction endonucleases (AflII, BclI, and BgIII). Hybridization with the 1.6-kb 32P-labeled probe (nucleotides 8299–
9921 of AL139349) showed the expected wild-type bands of 7.9 kb, 9.8 kb, and 9.2 kb, respectively. Additional bands (arrowheads) in the
obligate carrier (6.8 kb, 11.1 kb, and 7 kb, respectively) are compatible with a 4.4-kb deletion removing one AflII site, two BclI sites, and one
BglII site—all of which are centromeric of STX16 exon 2. C, Confirmation and exact localization of the deletion by PCR. Amplification across
the predicted location of the deletion, performed using one pair of primers (A [forward] and B [reverse]), yielded a 5.9-kb wild-type fragment
in the unaffected subject, the affected individual, and the obligate carrier; both the affected individual and the obligate carrier also showed a
shorter fragment (of 1.5 kb). Direct nucleotide sequence analysis of the short amplicon revealed the lack of 4,368 bp extending from nucleotide
704 to nucleotide 5072 of AL139349. D, Amplification of the STX16 region with four different primers, located at nucleotides 404 (primer C
[forward]), 1020 (primer D [reverse]), 4938 (primer E [forward]), and 5190 (primer F [reverse]) of AL139349. The sizes of expected wild-type
PCR products are 616 bp (primers C and D), 252 bp (primers E and F), and 4.8 kb (primers C and F [not shown]). Obligate carriers and
affected individuals show an additional 422-bp amplicon (arrow [primers C and F]). Results are shown for each individual in the family
(blackened symbols represent affected individuals, striped symbols represent obligate carriers, and unblackened symbols represent unaffected
individuals).
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sample from individual W-III/4. The sizes of these ad-
ditional bands were compatible with an ∼4.4-kb deletion
that removed one centromeric AflII site, two BclI sites,
and one BglII site.
To determine the exact location of the deletion, we
performed a series of PCRs with the use of primers that
were predicted to amplify a region of the mutant allele
spanning the deletion breakpoint. One set of primers
(primers A and B) amplified a single product of ∼5.9 kb
from genomic DNA of the unaffected individual W-III/
4, whereas the same primers produced an additional
smaller amplicon of ∼1.5 kb from DNA of the affected
individual W-III/3 and unaffected carrier W-II/5 (fig. 4A
and 4C). The difference between the lengths of the small
and the large amplicons was consistent with a 4.4-kb
deletion, suggesting that the small amplicon was derived
from the mutant allele. Direct nucleotide sequence an-
alysis of this mutant fragment showed that the dele-
tion occurred between nucleotides 704 and 5072 of
AL139349, thus eliminating exons 2–4 of STX16 (fig.
4C). The presence of this deletion was also confirmed
in the remaining affected individuals or unaffected car-
riers by multiplex PCR, performed using primers de-
signed to amplify across the deleted region and across
the predicted boundaries. All affected individuals and
obligate carriers of kindred W showed—in addition to
the wild-type products of 616 bp (primers C and D) and
252 bp (primers E and F)—a 422-bp product amplified
across the deletion breakpoints (primers C and F) (fig.
4A and 4D). In contrast, genomic DNA from the healthy
individuals generated only the two wild-type fragments;
note that the 4.8-kb product derived from the wild-type
allele (primers C and F) could not be routinely amplified,
because of its size (data not shown).
Biallelic Expression of STX16
Although the identified deletion removes coding exons
from the gene STX16, a loss-of-function mutation in one
STX16 allele could not directly explain the imprinted
AD-PHP-Ib phenotype unless STX16 itself is an im-
printed gene. We therefore examined allelic expression
of STX16 in total RNA extracted from lymphoblastoid
cells of a healthy control individual and of three AD-
PHP-Ib individuals carrying different mutations. STX16
normally gives rise to at least three differently spliced
mRNA transcripts: STX16A, STX16B, and STX16C
(AL050327 and AL139349 [fig. 5A]). RT-PCR ampli-
fication of total RNA from both the control individual
and subject C-II/1 (deletion of the NESP55 DMR [Bas-
tepe et al. 2005]), performed using primers G and H,
yielded products of 861 bp and 802 bp, corresponding
to isoform B of STX16 and its splice variant (which is
missing the alternatively spliced exon 4), respectively
(fig. 5B). Subsequent nucleotide sequence analysis of the
861-bp products revealed heterozygosity at position
527 of STX16 isoform B located within exon 4 (SNP
rs2296524 [fig. 5C]), indicating that both parental al-
leles were transcribed and amplified. Furthermore, RT-
PCR performed using lymphoblast-derived total RNA
of the affected individual W-III/3 (4.4-kb STX16 dele-
tion) showed amplicons from the wild-type splice vari-
ants of STX16 isoform B, as well as a shorter amplicon
of 449 bp (fig. 5A and 5B). Direct sequence analysis of
this short product confirmed the absence of nucleotides
derived from STX16 exons 2, 3, and 4. Likewise, tran-
scripts amplified by RT-PCR from individual F-III/37 (3-
kb STX16 deletion) included, in addition to the wild-
type splice variants of STX16 isoform B, a shortened
transcript represented by an amplicon of 462 bp (fig. 5A
and 5B). Nucleotide sequence analysis of this shorter
product confirmed the deletion of exons 4, 5, and 6.
Together, these findings suggested that both parental
STX16 alleles are transcribed in lymphoblastoid cells
and that the identified deletions do not appear to al-
ter this biallelic expression. We also searched the EST
database and identified two ESTs (CN348556 and
CN417685) matching the STX16 exon 8 sequence that
were derived from the same cDNA library yet differed
by one nucleotide (position 937 of STX16 isoform B;
position 11538 of AL139349). Since this nucleotide
change was also seen in several other ESTs from the
database, it indicated its polymorphic nature rather than
a sequence error. This finding strongly suggested that
STX16 mRNAs were amplified from both parental al-
leles in that particular library as well.
Discussion
We report a novel STX16 microdeletion of 4.4 kb in all
affected individuals and obligate carriers of a large kin-
dred with AD-PHP-Ib. This 4.4-kb microdeletion was
present in the unaffected mothers of the affected indi-
viduals ( ) and in the father of these obligate car-np 4
riers (figs. 2 and 4). This mode of inheritance is con-
cordant with the paternal imprinting of the disease in
this and other families with AD-PHP-Ib. The 4.4-kb mi-
crodeletion is the first STX16 mutation identified in pa-
tients with AD-PHP-Ib that differs from the 3-kb mi-
crodeletion present in multiple unrelated kindreds with
this disorder (Bastepe et al. 2003; Liu et al. 2005; Mah-
mud et al. 2005). Our findings thus provide further ev-
idence supporting the conclusion that STX16 harbors
an important element involved in the pathogenesis of
PHP-Ib. As the two deletions overlap by 1,286 bp, it is
likely that this element is contained in this overlap re-
gion. Thus far, of the 31 unrelated individuals with PHP-
Ib that we have investigated, 18 (58%) carry a deletion
within STX16 (Bastepe et al. 2003; Mahmud et al.
2005). Recently, the 3-kb deletion has also been found
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Figure 5 Biallelic expression of STX16. A, STX16 gives rise to at least three distinct transcripts (left). Isoform A (915 bp) differs from
isoform B (965 bp) by a shorter sequence derived from exon 1, whereas isoform C (422 bp) comprises this short exon 1 sequence as well as
exons 2–5 and terminates with exon 6a. In addition, exon 4 is alternatively spliced in each isoform, leading to a total of at least six variants.
Wild-type STX16 isoform B and the transcripts derived from individuals W-III/3 and F-III/37 (“mut1” and “mut2,” respectively) are depicted
(right). The 4.4-kb deletion (thick brackets) removes exons 2–4; the 3-kb deletion (thin brackets) removes exons 4–6. Exons are depicted as
blackened boxes, and direct repeats are shown as striped arrowheads. Primers G and H are represented as arrowed lines; cen p centromeric;
telp telomeric. B, RT-PCR analysis of STX16 transcripts in total RNA of immortalized lymphocytes from a healthy control individual (CTRL)
and the following individuals with AD-PHP-Ib: W-III/3 (present study), F-III/37 (carrying the 3-kb deletion in STX16 region [Bastepe et al.
2003]), and C-II/1 (carrying a deletion affecting NESP55 but not the STX16 region [Bastepe et al. 2005]). Reactions were performed with (“”)
or without (“”) reverse transcriptase, as described in the “Subjects and Methods” section. Products derived from the mutant alleles (“mut1”
and “mut2”) and from the wild-type alleles (“WT”) are indicated. Note that the wild-type products represent STX16 isoform B with or without
sequences derived from exon 4. C, Direct nucleotide sequence of STX16 isoform B amplified from RNA of a healthy control individual shows
heterozygosity at the polymorphic nucleotide 527, corresponding to SNP rs2296524.
in 5 of 20 unrelated individuals with PHP-Ib (Liu et al.
2005). Thus, mutations in this region are frequently the
cause of PHP-Ib. Affected individuals who carry the 3-
kb and 4.4-kb microdeletions exhibit loss of methylation
only at GNAS exon A/B; the methylation pattern is not
altered at other GNAS DMRs. Conversely, individuals
with PHP-Ib who lack such STX16 deletions display
methylation abnormalities at all GNAS DMRs (Bastepe
et al. 2003; Liu et al. 2005). On the basis of these find-
ings, we conclude that PHP-Ib comprises at least two
distinct conditions sharing the same clinical phenotype:
one is associated with the loss of exon A/B methylation
alone—and, in most of the cases, with a heterozygous
microdeletion in the STX16 region—and the other is
associated with methylation abnormalities at all GNAS
DMRs, including the DMR at exon A/B. In two unre-
lated kindreds with AD-PHP-Ib with broad methylation
defects of GNAS, we have recently identified deletions
affecting the NESP55 DMR (Bastepe et al. 2005), and
it remains to be determined whether the sporadic cases
with this epigenotype also carry an as-yet-undefined mi-
crodeletion within or close to this region.
Deletion of STX16 exons 2–4, caused by the muta-
tion presented in the present study, results in a frame-
shift and a premature termination codon following 20
new amino acids, whereas deletion of STX16 exons 4–
6, caused by the previously described 3-kb microdele-
tion (Bastepe et al. 2003), maintains the ORF. Thus, the
syntaxin-16 proteins generated by the 4.4-kb or 3-kb
deleted alleles either are shortened by 276 amino acids
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at the carboxyl-terminus or have a deletion of 133
amino acids in the midportion, respectively. Because of
these severe alterations, both products are predicted to
be nonfunctional, raising the question of whether syn-
taxin-16 deficiency may be responsible for the epigenetic
abnormality at GNAS exon A/B and the resulting PTH
resistance. However, this possibility seems unlikely for
two reasons. First, the previously reported lack of dif-
ferential methylation at the STX16 promoter (Bastepe
et al. 2003)—as well as our present demonstration of
biallelic expression of STX16 isoform B—strongly ar-
gues that this gene is not imprinted. Although not en-
tirely ruled out by our analysis, selective imprinting of
the other STX16 transcripts seems unlikely, given that
all the known transcripts apparently use the same pro-
moter. This lack of parental origin–specific STX16 ex-
pression is inconsistent with the imprinted mode of in-
heritance in kindreds with AD-PHP-Ib. Second, PTH
resistance can develop despite the presence of two intact
copies of STX16, as shown in a case of paternal uni-
parental isodisomy of chromosome 20q (Bastepe et al.
2001a). On the other hand, maternal inheritance of
STX16 mutations is associated with loss of methylation
at maternal GNAS exon A/B, and it is therefore more
likely that these deletions disrupt a cis-acting imprinting
control element (ICE) necessary for the methylation im-
print at exon A/B.
The novel 4.4-kb microdeletion overlaps with the for-
mer 3-kb deletion and therefore reduces the size of the
critical region containing the putative ICE for GNAS
exon A/B to 1,286 bp. This region encompasses the
centromeric direct repeat, and the flanking telomeric
sequence of 896 bp, which includes exon 4 of STX16
and intronic sequences of 244 bp and 344 bp on the
centromeric and telomeric side, respectively. We could
not identify, within the 1,286-bp overlapping region,
sequences or elements homologous to those previously
identified in other ICEs. For example, microdeletions at
the ICE of the IGF2/H19 locus abolish two CTCF bind-
ing sites required for the H19 DMR and thus result
in the Beckwith-Wiedemann syndrome (Sparago et al.
2004). Sequence analysis of the overlapping region en-
compassing exon 4 of STX16 did not reveal such known
CTCF sites. Another feature of ICEs is that they are
mostly located within CpG-rich sequences; in addition,
they display differential methylation (Spahn and Barlow
2003). Although the overlapping region includes a 140-
bp CpG-rich sequence within exon 4 (nucleotides 4572–
4711 of AL139349), we have shown elsewhere that this
region is not differentially methylated (Bastepe et al.
2003). It is therefore possible that the mechanisms gov-
erning the function of the identified ICE are different
from those of most other ICEs in the genome (Spahn
and Barlow 2003). Further investigations are necessary
to identify the specific features required for the proper
activity of the putative ICE.
Two candidate ICEs have been previously identified
in the mouse Gnas cluster: one comprising exon 1A
(homolog of human A/B) and the other comprising the
Gnasxl (homolog of human XLas) and Nespas pro-
moters (Liu et al. 2000b; Coombes et al. 2003). Mice
with a paternal ablation of exon 1A exhibit loss of Gas
silencing in cis, leading to expression of the Gas tran-
script from the paternal allele in brown fat and renal
proximal tubules (Williamson et al. 2004)—two tissues
in which Gas is normally expressed from the maternal
allele alone (Yu et al. 1998). This ablation does not alter
the imprinting of the other alternative transcripts, and
it therefore appears that a cis-acting element at exon
1A specifically regulates Gas expression in brown fat,
kidney, and perhaps other tissues. Findings in patients
with PHP-Ib indicate that this element allows active
transcription from the Gas promoter in the kidney only
when it is methylated (Liu et al. 2000a; Bastepe et al.
2001b). However, although the impact of this element
is confined to certain tissues, its methylation on the ma-
ternal GNAS allele appears to be ubiquitous (Liu et al.
2000b). Our findings in patients with AD-PHP-Ib pro-
vide evidence of another cis-acting element within the
overlapping region encompassing STX16 exon 4. The
latter appears to specifically control the methylation of
GNAS exon A/B and, thus, of the cis-acting element
regulating the tissue- and parent-specific expression of
Gas. Deletion of this putative STX16 ICE results in a
switch from a maternal to a paternal epigenotype at ex-
on A/B, thereby causing derepression of maternal A/B
transcription. Because the epigenetic changes associated
with the deletion of this putative element have been
identified in lymphocytes, its impact seems ubiquitous
rather than restricted to kidney and brown fat. In ad-
dition to this putative ICE that controls methylation on
a restricted area of GNAS (i.e., exon A/B), the identi-
fication of deletions of the NESP55 DMR in two un-
related families with AD-PHP-Ib has recently provided
evidence of an additional ICE that is involved in methy-
lation of the entire GNAS cluster (Bastepe et al. 2005).
Thus, in humans, maternal methylation at GNAS exon
A/B (and, hence, Gas transcription) requires at least two
ICEs: one at the STX16 locus, which affects exon A/B,
and the other at the NESP55 DMR, which affects all
the maternally methylated promoters within the GNAS
cluster.
Genetic analysis of cord blood (i.e., exon A/B meth-
ylation analysis and multiplex PCR) was particularly
useful, allowing us to rule out the diagnosis of AD-
PHP-Ib in one newborn and to establish the diagnosis
in another. The child with the genetic diagnosis of AD-
PHP-Ib was subsequently monitored with respect to de-
velopment of PTH resistance, and treatment eventually
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was started to prevent hypocalcemia and to avoid long-
term elevation of serum PTH; the latter can lead to
increased bone resorption, resulting from the apparent
absence of PTH resistance in this tissue. The observed
delay in the onset of PTH resistance in this patient is
consistent with past studies of individuals affected with
PHP-Ib (Marguet et al. 1997; Bastepe et al. 2001b) and
was also noted in patients with loss-of-function muta-
tions of Gas (i.e., PHP-Ia) (Weinstein et al. 2001). PTH
signaling through the PTH/PTHrP receptor, therefore,
seems intact in the renal proximal tubule during the
early postnatal period and infancy. One could hypoth-
esize that Gas is biallelically expressed in this tissue dur-
ing this specific period of development. Consistent with
this hypothesis, biallelic expression of Gas has been
shown by RT-PCR in whole kidneys and renal cortices
from mouse and human fetuses (Hayward et al. 1998a;
Zheng et al. 2001). However, these findings—which con-
tradict those showing the exclusive maternal expres-
sion of Gas in renal cortices of adult mice (Yu et al.
1998)—do not rule out the possibility that Gas expres-
sion is monoallelic in renal proximal tubules of fetal
or newborn kidney, especially considering that proximal
tubules constitute a small portion of the entire kidney.
Thus, there may be alternative possibilities to explain
the delay in the onset of PTH resistance. One of those
possible explanations may involve XLas, the paternally
expressed variant of Gas. XLas is expressed in multiple
fetal and adult tissues (Kehlenbach et al. 1994; Pasolli
et al. 2000), including murine kidney at postnatal day
4 (Plagge et al. 2004). Furthermore, on the basis of da-
ta from transfected cells lacking endogenous Gas and
XLas, XLas is capable of functionally coupling to the
PTH/PTHrP receptor (Bastepe et al. 2002). It is thus
possible that PTH actions during early postnatal period
are mediated through XLas.
In conclusion, in the present study, we have (1) iden-
tified a novel deletion in the STX16 locus as a cause of
AD-PHP-Ib and therefore established a strong associa-
tion between a unique epigenotype (i.e., loss of A/B meth-
ylation alone) and a genotype (i.e., microdeletion in-
volving STX16), (2) refined the boundaries of a putative
cis-acting ICE crucial for the establishment/maintenance
of methylation at GNAS exon A/B, (3) demonstrated
biallelic expression of STX16 mRNAs in lymphoblastoid
cells, and (4) established a molecular diagnosis that was
based on cord blood DNA in a patient, which helped in
the subsequent clinical management of that patient.
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